BYSI (BeyondSpring Inc.) Net earnings per share growth this year

BeyondSpring Inc. is developing innovative cancer treatments, enhancing chemotherapy efficacy through Plinabulin. The year-over-year change in EPS demonstrates profit dynamics, where 0.00 serves as the base value of the parameter. Investors' pragmatic approach to the brand platform combines with the high macro-resilience of the biotech sector, as the demand for oncology drugs remains independent of economic cycles.

Earnings per share growth in current year: BeyondSpring, Inc. (BYSI) for 07/04/2022 - 11/10/2026

Financial and market metric breakdowns for BeyondSpring Inc. (BYSI)

- stock quotes and analyst forecast:

Share Price BeyondSpring, Inc.|BYSI - Analyst Consensus Forecast

- business market valuation indicators:

Market Valuation BeyondSpring Inc|BYSI - Total Company Value

- company book value details:

Net Asset Value per Share BeyondSpring|BYSI - Company Book Value|Market Value to Book Value Ratio beyondspringpharma.com|BYSI - Aggregate Company Assets

- debt and liquidity details:

- company profitability and valuation multiples indicators:

BYSI - Net Profit|Expected Net Income BeyondSpring Inc.|BYSI - P/E Multiple|Projected Price to Earnings Ratio BeyondSpring Inc|BYSI - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation BeyondSpring Inc|BYSI - Operating profit EBITDA|Net earnings per share (EPS TTM) BeyondSpring|BYSI - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months beyondspringpharma.com|BYSI - Net earnings per share growth this year|Expected net earnings per share growth next year BeyondSpring Inc.

Summary company analysis:BYSI BeyondSpring, Inc.

BeyondSpring Inc. focuses on developing specialized oncology drugs, where success depends on regulatory approvals. Earnings per share dynamics are sensitive to R&D expenditures and the commercial rollout of medications. This indicator measures the annual growth of net income, reflecting the efficiency of capital generation relative to the previous year. A positive trend confirms the scaling of the business. By analyzing the annual EPS growth chart, an investor assesses the company's resilience to market competition.

Key competitors